| abstract |
Combination treatments, wherein a 5-LOX inhibitor are administered together with a bone or cartilage beneficial compound in order to obtain a therapeutically beneficial effect in the treatment and/or prophylaxis of osteoarthritis, rheumatoid arthritis, osteoporosis or pain, and pharmaceutical compositions comprising a combination of a 5-LOX inhibitor and a bone and cartilage beneficial compound. |